Cosmos Health reports record FY2025 revenue $65.3M, up 20%; gross profit +83%, adjusted EPS improves 82%

Cosmos Health Inc.

Revenue $65.3M (+20% YoY); gross profit $7.9M (+83%); gross margin 12.1% (+418 bps).
Adjusted EPS improved to ($0.12) from ($0.65) (+82%); adjusted EBITDA loss narrowed to $3.36M.
Cash and equivalents $3.5M, up 10x from $0.3M; total assets $65.5M (+21%).
CEO Greg Siokas increased ownership by 3.3M shares; secured $300M digital asset financing facility.
Contract manufacturing deals for 12M+ units; Sky Premium Life 60 new SKUs; U.S. expansion with NOOR Collagen.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cosmos Health Inc. reported the full year ended December 31, 2025 results: revenue $65.27 million, net income ($19.14 million), EPS ($0.63).

Period: the full year ended December 31, 2025
Revenue: $65.27 million
Net income: ($19.14 million)
EPS: ($0.63)
Result: reported results

Exact text from the filing

through Decahedron in the United Kingdom, and the global expansion of proprietary brands, including Sky Premium Life and C-Scrub. Key Metric FY 2025 FY 2024 Change (in $) Revenue 65,271,815 54,426,402 +20 % Gross Profit 7,895,575 4,311,323 +83 % Gross Margin 12.10 % 7.92 % +418 basis points Adjusted EBITDA (3,361,385 ) (3,438,975 ) 2% improvement Adjusted Net Income

View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

Cosmos Health Inc. filing history →

Source: SEC EDGAR

accession 0001477932-26-002316

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.